Shah N, Russo M
World J Hepatol. 2017; 9(5):288-292.
PMID: 28261386
PMC: 5316849.
DOI: 10.4254/wjh.v9.i5.288.
Spec A, Raval K, Powderly W
Open Forum Infect Dis. 2016; 3(1):ofv197.
PMID: 26835475
PMC: 4730110.
DOI: 10.1093/ofid/ofv197.
Bruns T, Zimmermann H, Stallmach A
World J Gastroenterol. 2014; 20(10):2542-54.
PMID: 24627590
PMC: 3949263.
DOI: 10.3748/wjg.v20.i10.2542.
Chuang Y, Ho Y, Chang H, Yu C, Yang P, Hsueh P
Eur J Clin Microbiol Infect Dis. 2007; 27(4):307-10.
PMID: 18157678
DOI: 10.1007/s10096-007-0430-1.
Fiuza C, Salcedo M, Clemente G, Tellado J
Clin Diagn Lab Immunol. 2002; 9(2):433-9.
PMID: 11874890
PMC: 119958.
DOI: 10.1128/cdli.9.2.433-439.2002.
Increased soluble ICAM-1 concentration and impaired delayed-type hypersensitivity skin tests in patients with chronic liver disease.
Pirisi M, Vitulli D, Falleti E, Fabris C, Soardo G, Del Forno M
J Clin Pathol. 1997; 50(1):50-3.
PMID: 9059357
PMC: 499713.
DOI: 10.1136/jcp.50.1.50.
T-lymphocyte transformation in experimental obstructive jaundice: the role of serum-suppressive factors.
Thompson R, Ranjbar S, Rowlands B
World J Surg. 1993; 17(6):783-5.
PMID: 8109118
DOI: 10.1007/BF01659096.
Serum regulation of in vitro lymphocyte responses in early experimental syphilis.
Sell S, Lukehart S
Infect Immun. 1982; 37(2):568-78.
PMID: 6749683
PMC: 347571.
DOI: 10.1128/iai.37.2.568-578.1982.
Mouse serum factor depressing lymphocyte transformation.
Nelson D
Experientia. 1972; 28(10):1227-8.
PMID: 5087048
DOI: 10.1007/BF01946187.
The effects of foetuin on lymphocytes: lymphocyte-stimulating property.
Hsu C, WAITHE W, HATHAWAY P, Hirschhorn K
Clin Exp Immunol. 1973; 15(3):427-34.
PMID: 4764349
PMC: 1553903.
The primary immune response to haemocyanin in patients with primary biliary cirrhosis.
Fox R, DUDLEY F, Sherlock S
Clin Exp Immunol. 1973; 14(4):473-80.
PMID: 4747579
PMC: 1553816.
In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis.
BERENYI M, STRAUS B, Cruz D
Am J Dig Dis. 1974; 19(3):199-205.
PMID: 4596642
DOI: 10.1007/BF01072535.
Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors.
MacSween R, Thomas M
Clin Exp Immunol. 1973; 15(4):523-33.
PMID: 4544318
PMC: 1553970.
Lymphocyte transformation in response to phytohaemagglutinin in primary biliary cirrhosis: the search for a plasma inhibitory factor.
Fox R, DUDLEY F, Samuels M, Milligan J, Sherlock S
Gut. 1973; 14(2):89-93.
PMID: 4540493
PMC: 1412553.
DOI: 10.1136/gut.14.2.89.
Immunological studies in acute myeloid leukaemia: PHA responsiveness and serum inhibitory factors.
Walker J, Davis D, Davies P, Freeman C, Harris R
Br J Cancer. 1973; 27(3):203-11.
PMID: 4511988
PMC: 2008775.
DOI: 10.1038/bjc.1973.25.
Lymphocyte tissue culture studies on human heart transplant recipients. I. Screening recipients for serum factors which inhibit the mixed lymphocyte reaction.
Coulson A, Macmillan F, Griepp R, Stinson E, DONG Jr E, Shumway N
Ann Surg. 1974; 179(6):930-6.
PMID: 4275598
PMC: 1355928.
DOI: 10.1097/00000658-197406000-00020.
Delayed homograft rejection following common bile duct ligation: in vivo evidence that obstructive jaundice is immunosuppressive.
Keane R, Collins P, Johnson A, Bouchier Hayes D
Ir J Med Sci. 1986; 155(5):143-6.
PMID: 3525452
DOI: 10.1007/BF02939848.
Decreased proliferative activity associated with activation markers in patients with alcoholic liver cirrhosis.
Deviere J, Denys C, Schandene L, Romasco F, Adler M, Wybran J
Clin Exp Immunol. 1988; 72(3):377-82.
PMID: 3262458
PMC: 1541554.
Soluble interleukin-2 receptor and soluble CD8 in liver cirrhosis and obstructive jaundice.
Wagner F, Assemi C, Lersch C, Hart R, Classen M
Clin Exp Immunol. 1990; 82(2):344-9.
PMID: 2122935
PMC: 1535106.
DOI: 10.1111/j.1365-2249.1990.tb05450.x.
AIDS, drugs of abuse and the immune system: a complex immunotoxicological network.
Pillai R, Nair B, Watson R
Arch Toxicol. 1991; 65(8):609-17.
PMID: 1747059
DOI: 10.1007/BF02098025.